NCT00379249已完成3 期
Effects of a Twelve Months ROSUVASTATIN Treatment Plus Additional Care (Drug Intake Adherence and Lifestyle Enhancing Initiatives ) Compared to ROSUVASTATIN Treatment Alone on Long-Term Disease-Related Costs in Patients With an Indication for Statin Treatment According to the Joint European Guidelines
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 8,000
- 主要终点
- Cumulative direct/indirect disease-related costs were compared applying a societal perspective
研究概览
简要总结
The primary objective of the study is to compare the effect of rosuvastatin therapy plus compliance initiatives and rosuvastatin therapy alone for 12 months (52 weeks) on long-term cumulative direct and indirect disease-related costs during the 36 month.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •high cholesterol with an indication for cholesterol-lowering medication (statins)
排除标准
- •contra-indications for statin therapy
结局指标
主要结局
Cumulative direct/indirect disease-related costs were compared applying a societal perspective
Costs include resource utilization for ambulatory, hospital, rehabilitative and nursing care, medication, physiotherapy, transportation, and productivity loss)
次要结局
- Achievement of the 1998 European LDL-C goal of <115 mg/dL (3.0 mmol/L)
- Changes in the lipid profile and compliance with therapy.
研究者
相似试验
已完成
3 期
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome SubjectsMetabolic SyndromeNCT00654485AstraZeneca940
已完成
4 期
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart DiseaseHypercholesteremiaNCT00329160AstraZeneca214
Unknown
不适用
Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS PatientsAcute Coronary SyndromeNCT02420899Beijing Friendship Hospital100
已完成
3 期
Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 WeeksHypercholesterolemiaCoronary Heart DiseaseNCT00653588AstraZeneca
已完成
3 期
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)DyslipidaemiaHypercholesterolemiaNCT00653744AstraZeneca1,700